J Korean Liver Cancer Stud Search


Journal of the Korean Liver Cancer Study 2007;7(1):98-102.
Published online June 30, 2007.
A Case of Combined Hepatocellular-Cholangiocarcinoma
Kee Sup Song1, Young Saeng Kim1, Uk Sun Chang1, Oh Sang Kwon1, Yun Soo Kim1, Duck Ju Choi1, Ju Hyun Kim1, Ha Na Kim2, Jee Hee Kang2, Jung Ho Kim2, Jae Hong Park3, Dong Hae Jung3, Keon Kuk Kim4
1Departments of Internal Medicine, Gachon Medical College, Inchon, Korea
2Departments of Diagnostic Radiology, Gachon Medical College, Inchon, Korea
3Departments of Pathology, Gachon Medical College, Inchon, Korea
4Departments of General Surgery, Gachon Medical College, Inchon, Korea
Correspondence:  Yun Soo Kim,
Email: kimys@gilhospital.com
Copyright ©2007 by The Korean Liver Cancer Association
Combined hepatocellular-cholangiocarcinoma (HCC-CC) is a rare form of primary liver cancer, featuring both hepatocellular and biliary epithelial differentiation. A 49-year-old man who was chronic HBV carrier complained of generalized weakness for 1 month. Abdominal CT scan and MRI showed a 3 cm-sized, hypodense mass in S6 of the liver with contrast enhancement. Percutaneous ultrasound-guided core needle biopsy of the liver yielded HCC-CC, and transarterial chemoembolization was done. Abdominal CT scan taken 2 weeks after TACE showed a partial uptake of lipiodol and then he underwent right posterior segmentectomy. The surgical specimen showed complete necrosis and no viable tumor cell. He was discharged without any complication.
Key Words: Combined hepatocellular-cholangiocarcinoma


Browse all articles >

Editorial Office
1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2020 by The Korean Liver Cancer Association. All rights reserved.

Developed in M2community

Close layer
prev next